|
Journal of Perinatology
|
|
|
January/February 2000, Volume 20, Issue 1, Pages 41 - 45 |
![]() |
|
Journal Home |
||
| <- Previous | Issue Contents | Next -> |
| Original Article |
|
Pulmonary Function and Electrolyte Balance Following Spironolactone Treatment in Preterm Infants With Chronic Lung Disease: A Double-Blind, Placebo-Controlled, Randomized Trial Correspondence to: This work was funded by the Newborn Pediatrics Research Fund. D. J. H. was supported in part by a training grant from the National Institutes of Health (HL-07027). Presented in part at the annual meeting of The Society for Pediatric Research, Washington, DC, May 1997. |
| Abstract |
OBJECTIVE: To study the effect of spironolactone on dietary electrolyte supplementation, pulmonary function, and electrolyte balance in premature infants with chronic lung disease. STUDY DESIGN A double-blind, randomized, and placebo-controlled trial was designed to study two groups of low birth weight infants with chronic lung disease at Pennsylvania Hospital. The placebo group received chlorothiazide and a placebo, and the spironolactone group received chlorothiazide and spironolactone during the 2-week study period. A two-tailed t-test was used to determine equivalence between the two groups. RESULTS Pulmonary compliance, resistance and tidal volume, serum sodium and potassium, and FIO2, were not statistically different between the two groups. The need for sodium and/or potassium chloride did not differ between the two groups, nor did the quantity of each salt. CONCLUSION The addition of spironolactone did not reduce the requirement for supplemental electrolytes, nor did it improve pulmonary mechanics or electrolyte balance. |